GlaxoSmithKline
GSK
#289
Rank
NZ$117.30 B
Marketcap
$57.50
Share price
1.05%
Change (1 day)
-1.09%
Change (1 year)

GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

Volume in USD (price x number of shares), data since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$54.44 M82.06%
2023NZ$29.9 M-43.98%
2022NZ$53.37 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$31.61 MNZ$0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$50.21 MNZ$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.45 MNZ$88.44 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.57 MNZ$74.81 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$11.64 MNZ$71.88 M๐Ÿ‡ซ๐Ÿ‡ท France
NZ$9.38 MNZ$32.19 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$8.39 MNZ$32.61 M๐Ÿ‡บ๐Ÿ‡ธ USA